C-reactive protein (CRP) is a serum protein which is found in greatly increased concentrations in conditions of inflammation and tissue injury. Although a great deal has been learned about the structure and binding characteristics of CRP, its biological function remains unclear (4) . CRP binds to three types of ligand: phosphocholine found in substances such as the pneumococcal C-polysaccharide (14, 17) , polycations (2) , and polysaccharides containing galactose or N-acetylgalactosamine (5, 15, 16) . CRP binding can lead to complement activation by the classical pathway (6) and, in the presence of complement, can enhance opsonization of C-polysaccharide-sensitized erythrocytes (11) and type 27 Streptococcus pneumoniae (2a) . Injection of CRP increased survival in mice challenged with type 3 or type 4 S. pneumoniae (9) .
Two earlier studies have reported CRP binding to a limited range of bacteria. Patterson and Higginbotham (12) found that mouse CRP-agglutinated Staphylococcus aureus, S. pneumoniae, alpha-and beta-hemolytic streptococci, and Bacillus subtilis. Escherichia coli was not agglutinated, and the authors suggested a general reactivity of CRP with gram-positive organisms. Kindmark (7) measured CRP binding by the ability of bacteria to selectively absorb CRP from acute-phase human serum and reported substantial CRP binding to S. pneumoniae, a much smaller amount of binding to E. coli, and no binding to S. aureus.
To assess a potential role for CRP in defense against bacterial infection, it is important to determine the range of bacteria to which CRP binds. We have therefore measured binding of purified radioiodinated human CRP to clinical isolates of different bacterial species.
Bacterial CRP was purified and radioiodinated as previously described (10) . Bacteria were incubated with radioiodinated CRP for 30 min at 37°C in Veronal-buffered saline (pH 7.4), containing 1 mM CaCl2 (VBS-Ca2+) or 10 mM EDTA (VBS-EDTA). Bacteria were washed in the same buffer and counted for bound 1251. To screen for CRP binding, bacteria from overnight plate cultures were washed and suspended in saline. Dilutions of the bacterial suspension were plated to determine the number of bacteria or added to 25 ,ug of 125I-CRP to measure binding. For quantitative determinations of CRP binding, bacteria were grown to log phase in broth, washed, and resuspended in saline. S. pneumoniae isolates were heated for 30 min at 56°C, a procedure which was shown not to affect CRP binding. Different amounts of CRP between 1 and 200 ,ug were added to a concentration of bacteria which bound 50% of 125I-CRP in the screening assay. CRP binding in VBS-EDTA was always less than 5%, and these values were subtracted from the binding observed in VBSCa2 . Estimates of CRP binding at saturation were determined from Scatchard analysis of the binding data (13). (1) .
Among the other streptococci tested, no CRP binding was found with group A or group B streptococci. Two of six different clinical isolates in the viridans group showed CRP binding. An additional two of three viridans streptococci isolated from normal saliva and identified as Streptococcus mitis bound significant amounts of CRP (not shown).
One nonclinical isolate of Staphylococcus aureus was found to bind a small amount of CRP. However, no binding was observed with two S. aureus isolates from patients with toxic shock syndrome or with Staphylococcus epidermidis cultured from normal skin. Staphylococcal protein A-Sepharose (Pharmacia Fine Chemicals, Uppsala, Sweden) also did not bind CRP.
None of the eight gram-negative species tested bound CRP. These included Enterobacteriaceae (Escherichia coli, Salmonella, and Klebsiella pneumoniae), gram-negative nonfermenting organisms ( (2a, 11) and contribute to host defense (9) may be specific for infection with S. pneumoniae.
